Seroprevalence and Risk Factors of Crimean-Congo Hemorrhagic Fever in Selected Seven Provinces in Turkey

被引:31
|
作者
Yagci-Caglayik, Dilek [1 ]
Korukluoglu, Gulay [1 ]
Uyar, Yavuz [1 ]
机构
[1] Publ Hlth Inst Turkey, Dept Microbiol Reference Labs, Virol Reference & Res Lab, TR-06100 Ankara, Turkey
基金
欧盟第七框架计划;
关键词
Crimean-Congo hemorrhagic fever virus; seroprevalence; antibody; risk factor; adobe house; Turkey; VIRUS TRANSMISSION; EPIDEMIOLOGY; OUTBREAKS; REGIONS;
D O I
10.1002/jmv.23699
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Turkey has been one of the most endemic regions since 2002, when Crimean-Congo hemorrhagic fever emerged worldwide. The aim of the present study was to estimate the seroprevelance of CCHF virus in humans who reside in rural and urban areas of known endemic and nonendemic selected provinces of Turkey by using commercial ELISA kit. CCHFV IgG antibodies were detected in 2.3% of the population. The most important risk factors for CCHF seropositivity, were older age, male gender, illiterate, farmer, animal husbandry, living in rural residence in adobe houses, and a previous tick bite history. J. Med. Virol. 86:306-314, 2014. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:306 / 314
页数:9
相关论文
共 50 条
  • [31] Seroprevalence of Crimean-Congo haemorrhagic fever (CCHF) in risk groups in Tokat Province of Turkey
    Tekin, Saban
    Barut, Sener
    Bursali, Ahmet
    Aydogan, Gul
    Yuce, Onem
    Demir, Fatma
    Yildirim, Beytullah
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2010, 4 (03): : 214 - 217
  • [32] Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy
    Ozkurt, Z
    Kiki, H
    Erol, S
    Erdem, F
    Yilmaz, N
    Partak, M
    Gundogdu, M
    Tasyaran, MA
    JOURNAL OF INFECTION, 2006, 52 (03) : 207 - 215
  • [33] Crimean-Congo Hemorrhagic Fever: An Overview
    Serkan ncü
    Virologica Sinica, 2013, (04) : 193 - 201
  • [34] Diagnosis of Crimean-Congo hemorrhagic fever
    Tezer, Hasan
    Polat, Meltem
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (05) : 555 - 566
  • [35] Crimean-Congo Hemorrhagic Fever, Mauritania
    Boushab, Boushab Mohamed
    Kelly, Mamadou
    Kebe, Hasmiou
    Bollahi, Mohamed Abdallahi
    Basco, Leonardo K.
    EMERGING INFECTIOUS DISEASES, 2020, 26 (04) : 817 - 818
  • [36] Crimean-Congo Hemorrhagic Fever in Tajikistan
    Tishkova, Farida H.
    Belobrova, Evgeniya A.
    Valikhodzhaeva, Matlyuba
    Atkinson, Barry
    Hewson, Roger
    Mullojonova, Manija
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2012, 12 (09) : 722 - 726
  • [37] Pathogenesis of Crimean-Congo Hemorrhagic Fever
    Akinci, Esragul
    Bodur, Hurrem
    Leblebicioglu, Hakan
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2013, 13 (07) : 429 - 437
  • [38] Emergence of Crimean-Congo hemorrhagic fever
    Leblebicioglu, Hakan
    Ozaras, Resat
    Erciyas-Yavuz, Kiraz
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (11) : 676 - 678
  • [39] Imported Crimean-Congo hemorrhagic fever
    Jauréguiberry, S
    Tattevin, P
    Tarantola, A
    Legay, F
    Tall, A
    Nabeth, P
    Zeller, H
    Michelet, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4905 - 4907
  • [40] Crimean-Congo hemorrhagic fever in children
    Tezer, Hasan
    Sucakli, Iclal Ayranci
    Sayli, Tulin Revide
    Celikel, Elif
    Yakut, Ibrahim
    Kara, Ates
    Tunc, Bahattin
    Ergonul, Onder
    JOURNAL OF CLINICAL VIROLOGY, 2010, 48 (03) : 184 - 186